The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
RayzeBio Inc(NASDAQ:RYZB)


RayzeBio is a clinical-stage radiopharmaceutical therapeutics (“RPT”) company with an innovation-leading position in actinium-based RPTs and a pipeline of potentially first-in-class and best-in-class drug development programs.
Website: https://rayzebio.com/
Founded: 2020
CEO: Dr. Kenneth Song
Sector: Healthcare
Industry: Biotechnology
RayzeBio Op Cashflow Per Share ttm
RayzeBio Free Cashflow Per Share ttm
RayzeBio Cash Per Share ttm
RayzeBio (GAAP) P/E ratio ttm
RayzeBio P/B ratio ttm
No extra charts and metrics for this ticker.